stride study semaglutide American College of Cardiology on X: "The trial demonstrated that significantly improves function, symptoms, and health-related QoL in patients with symptomatic #cvPAD and T2DM. Get the full clinical trial details ACC 25 Late-Breaking Discussion: STRIDE:

Once opened, Ozempic is good for 56 days at room temperature

Acting on the gastrointestinal tract Gastrointestinal reactions are the most common adverse reactions of GLP1 capsules, and their mechanism of occurrence is closely related to the widespread distribution of GLP1 receptors in the gastrointestinal tract

If you are deciding between the two, the choice typically comes down to whether the GIP component of tirzepatide is worth the potentially higher cost and different side effect profile

For type 2 diabetes management , licensed GLP-1 medications include: Exenatide (Byetta, Bydureon) available as twice-daily or once-weekly formulations Liraglutide (Victoza) administered once daily Dulaglutide (Trulicity) given once weekly Semaglutide (Ozempic) administered once weekly as an injection Semaglutide (Rybelsus) taken orally once daily (for type 2 diabetes only, not licensed for weight management) For weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, two medications hold specific licences: Liraglutide 3.0 mg (Saxenda) once-daily subcutaneous injection Semaglutide 2.4 mg (Wegovy) once-weekly subcutaneous injection Access to these medications through the NHS is governed by NICE guidance

These treatments receive clearance from top regulators in India, following a comprehensive evaluation of the risk-to-benefit ratio

Also see: Which vitamins and minerals should be taken together or separately